In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist

Kappa-opioid receptor (KOR) antagonists are promising innovative therapeutics for the treatment of the central nervous system (CNS) disorders. The new scaffold opioid ligand, Compound A, was originally found as a mu-opioid receptor (MOR) antagonist but its binding/selectivity and activation profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Puls, Kristina, Olivé-Marti, Aina-Leonor, Pach, Szymon, Pinter, Birgit, Erli, Filippo, Wolber, Gerhard, Spetea, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229160/
https://www.ncbi.nlm.nih.gov/pubmed/35745598
http://dx.doi.org/10.3390/ph15060680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229160/
https://www.ncbi.nlm.nih.gov/pubmed/35745598
http://dx.doi.org/10.3390/ph15060680

Ejemplares similares